<i>RAS</i> Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF InhibitorsFei Su, Jeffrey A. Sosman, Gideon Bollag et al.|New England Journal of Medicine|2012Cited by 1k
Post-immunotherapy CTLA-4 Ig treatment improves antitumor efficacyStephen Mok, James P. Allison|Proceedings of the National Academy of Sciences|2024Cited by 19